Virus-like particle vaccines by Mukhopadhyay, E, Hill, AVS, Salman, AM

“…Vaccines are among the most successful and cost-effective public health tools for preventing infectious diseases and death. …”

The use of complete genome sequences in vaccine design. by Saunders, N, Butcher, S

Strategies in the design and use of synthetic "internal glycan" vaccines by Lakshminarayanan, A, Vijayakrishnan, B, Bayley, H, Davis, B

“…The relative structural conservation of "internal glycans" in the cell walls of pathogens suggests that they might as target epitopes less prone to variation and hence with greater potential universality as vaccine targets. Examples of such glycans include the inner core sugars of lipopolysaccharides in Gram-negative bacteria. …”

From mask to vaccine diplomacy: geopolitical competition in the Western Balkans by Tzifakis, N, Prelec, T

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy by Vermaak, S, Sampson, S, McShane, H

“…Established in June 2017, VALIDATE is an international network of researchers working to accelerate vaccine development for four neglected intracellular pathogens that cause significant mortality and morbidity globally: Mycobacterium tuberculosis, Leishmania spp., Burkholderia pseudomallei and Mycobacterium leprae. …”

Genetic immunisation by Johnson, T, Giubilini, A

“…Vaccination must continue to be supported, but for parents who are already undertaking IVF, genetic immunisation may become the new vaccination. …”

Genetic immunization: enhancement or public health measure? by Johnson, T

“…“Genetic immunization” may be considered the new vaccination in the future, rendering not only enhanced individuals, but also wider communities immune to specific infectious diseases. …”

Musteloid diseases: implications for conservation and species management by Newman, C, Byrne, A

“…Managing host density, vaccination and host isolation are thus the best tools for managing disease, where we advocate the UN-led ‘One Health approach, aimed at reducing risks of infectious diseases at the Animal-Human-Ecosystem interface</p>…”

Fortune and the prepared mind by Morley, I, de Rond, M

“…Aside from bringing us such powerful agents as aspirin, the contraceptive pill, penicillin, laughing gas, vaccination, vitamin K, amphetamine, antihistamines, benzodiazepines, quinine, insulin, sulfa drugs, valproic acid, propafenone, magainins, nitrogen mustard, nitroglycerin, warfarin, the smallpox vaccine and cloretazine, it produced Scotchgard, Teflon, Velcro, Nylon, the Post-it Note, Kodak’s Weekender camera, the technology behind the HP Inkjet printer (based on seeing a coffee percolator at work), electromagnetism, photography, dynamite, the phonograph, X-rays, radioactivity, and even Ivory Soap, liquorice allsorts and Coca Cola (patented, in 1886, as ‘Pemberton’s French Wine Coca’ for medicinal purposes, as a nerve and tonic stimulant and a possible cure for headaches). …”

Challenges in developing a controlled human tuberculosis challenge model by Jackson, S, McShane, H

“…Furthermore, the only licensed vaccine, BCG, is a century old and demonstrates limited efficacy in adults from endemic areas. …”

Correlates of protection from tuberculosis by Peralta Alvarez, MP, Marshall, JL, Tanner, R

“…However, development of a much-needed new and effective TB vaccine is hindered by the lack of validated correlates of protection. …”

Bacterial infections and nutrition - a primer by Berkley, JA

“…The effects of undernutrition on responses to vaccines against bacterial pathogens and the effects of antimicrobials on growth are addressed. …”

Cultured ELISpot assay to investigate dengue virus specific T-cell responses by Jeewandara, C, Ogg, GS, Malavige, GN

“…Therefore, this assay is likely to be useful in determining the past infecting DENV serotype in immune-epidemiological studies and in dengue vaccine trials.…”

What viruses want: evolutionary insights for the Covid-19 pandemic and lessons for the next one by Johnson, DDP

“…Despite herculean efforts in public policy and the development of treatments and vaccines, viruses are often able to stay one step ahead precisely because they are evolving, and quickly. …”

The genus Neisseria by Bennett, J, Bratcher, H, Brehony, C, Harrison, O, Maiden, M

“…The majority of work on the genus concentrates on the two pathogenic species, with attempts to develop a comprehensive vaccine against the meningococcus a major driver for research. …”